Home › Stocks › BDRX › Changes
Who bought & sold BDRX (Q2 2026)
Funds holding (Q2 2026)8
New positions1
Added1
Reduced6
Exited1
As of Q2 2026, 8 institutional funds reported holding BDRX (BIODEXA PHARMACEUTICALS PLC): 1 opened new positions, 1 added, 6 trimmed and 1 exited entirely. 13F filings are quarter-end snapshots of positioning, not intra-quarter trades.
New positions (1)
| Fund | Shares | Value | Weight |
|---|---|---|---|
| Allied Private Wealth LLC New | 489 | $1.27K | 0.0 |
Added to positions (1)
| Fund | Shares | Value | Weight | Change |
|---|---|---|---|---|
| Caitong International Asset Management Co., Ltd | 5 | $15 | — | +4 sh (+400.0%) |
Reduced positions (6)
| Fund | Shares | Value | Weight | Change |
|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 14.81K | $43.09K | 0.0 | -82.71K sh (-84.8%) |
| GAMMA Investing LLC | 1.20K | $3.50K | — | -12.58K sh (-91.3%) |
| SBI Securities Co., Ltd. | 29 | $84 | — | -122 sh (-80.8%) |
| UBS Group AG | 25 | $73 | — | -102 sh (-80.3%) |
| Hilton Head Capital Partners, LLC | 6 | $17 | — | -24 sh (-80.0%) |
| RHUMBLINE ADVISERS | 3 | $8 | — | -16 sh (-84.2%) |
Exited positions (1)
Held in the prior quarter but not reported in the latest filing.
| Fund | Shares | Value | Weight |
|---|---|---|---|
| SABBY MANAGEMENT, LLC Exited | 257.47K | $159.09K | 1.9 |